Cargando…

Effects of COVID-19 on cognition and mood after hospitalization and at 2-month follow-up

A plethora of evidence links SARS-CoV-2 infection with concomitant cognitive dysfunction, which often persists weeks to months after the acute stages of illness and affects executive function, attention, memory, orientation, and movement control. It remains largely unclear which conditions or factor...

Descripción completa

Detalles Bibliográficos
Autores principales: Peskar, Manca, Šimunič, Boštjan, Šlosar, Luka, Pišot, Saša, Teraž, Kaja, Gasparini, Mladen, Pišot, Rado, Marusic, Uros
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252562/
https://www.ncbi.nlm.nih.gov/pubmed/37303911
http://dx.doi.org/10.3389/fpsyg.2023.1141809
_version_ 1785056200614739968
author Peskar, Manca
Šimunič, Boštjan
Šlosar, Luka
Pišot, Saša
Teraž, Kaja
Gasparini, Mladen
Pišot, Rado
Marusic, Uros
author_facet Peskar, Manca
Šimunič, Boštjan
Šlosar, Luka
Pišot, Saša
Teraž, Kaja
Gasparini, Mladen
Pišot, Rado
Marusic, Uros
author_sort Peskar, Manca
collection PubMed
description A plethora of evidence links SARS-CoV-2 infection with concomitant cognitive dysfunction, which often persists weeks to months after the acute stages of illness and affects executive function, attention, memory, orientation, and movement control. It remains largely unclear which conditions or factors exacerbate the recovery. In a cohort of N=37 Slovenian patients (5 females, aged M = 58, SD = 10.7 years) that were hospitalized because of COVID-19, the cognitive function and mood states were assessed immediately after discharge and 2-months later to investigate the early post-COVID recovery changes. We assessed the global Montreal Cognitive Assessment (MoCA), Simple and Choice Reaction Times, executive functions (Trail-Making Test – TMT-A and TMT-B), short-term memory (Auditory Verbal Learning Test – AVLT), and visuospatial memory. We monitored depressive and anxiety symptoms and applied general self-efficacy and cognitive complaints questionnaires. Our results showed a global cognitive impairment (MoCA, Z = 332.5; p = 0.012), poorer performance on executive functions (TMT-A, Z = 188; p = 0.014; and TMT-B, Z = 185; p = 0.012), verbal memory (AVLT, F = 33.4; p < 0.001), and delayed recall (AVLT7, F = 17.1; p < 0.001), and higher depressive (Z = 145; p = 0.015) and anxiety (Z = 141; p = 0.003) symptoms after hospital discharge compared to 2-month follow-up, indicating that SARS-CoV-2 may transiently impair cognitive function and adversely affect the mood. No improvement in MoCA was observed in 40.5% of the patients at follow-up, indicating possible long-term effects of COVID-19 on global cognitive performance. Medical comorbidities (p = 0.035) significantly predicted the change in MoCA score over time, while fat mass (FM, p = 0.518), Mediterranean diet index (p = .0.944), and Florida Cognitive Activities Score (p = 0.927) did not. These results suggest that the patients’ medical comorbidities at the time of SARS-CoV-2 infection could importantly contribute to the acute impairment of cognitive function and stress the importance of systemic implementation of countermeasures to limit the negative consequences on public health.
format Online
Article
Text
id pubmed-10252562
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-102525622023-06-10 Effects of COVID-19 on cognition and mood after hospitalization and at 2-month follow-up Peskar, Manca Šimunič, Boštjan Šlosar, Luka Pišot, Saša Teraž, Kaja Gasparini, Mladen Pišot, Rado Marusic, Uros Front Psychol Psychology A plethora of evidence links SARS-CoV-2 infection with concomitant cognitive dysfunction, which often persists weeks to months after the acute stages of illness and affects executive function, attention, memory, orientation, and movement control. It remains largely unclear which conditions or factors exacerbate the recovery. In a cohort of N=37 Slovenian patients (5 females, aged M = 58, SD = 10.7 years) that were hospitalized because of COVID-19, the cognitive function and mood states were assessed immediately after discharge and 2-months later to investigate the early post-COVID recovery changes. We assessed the global Montreal Cognitive Assessment (MoCA), Simple and Choice Reaction Times, executive functions (Trail-Making Test – TMT-A and TMT-B), short-term memory (Auditory Verbal Learning Test – AVLT), and visuospatial memory. We monitored depressive and anxiety symptoms and applied general self-efficacy and cognitive complaints questionnaires. Our results showed a global cognitive impairment (MoCA, Z = 332.5; p = 0.012), poorer performance on executive functions (TMT-A, Z = 188; p = 0.014; and TMT-B, Z = 185; p = 0.012), verbal memory (AVLT, F = 33.4; p < 0.001), and delayed recall (AVLT7, F = 17.1; p < 0.001), and higher depressive (Z = 145; p = 0.015) and anxiety (Z = 141; p = 0.003) symptoms after hospital discharge compared to 2-month follow-up, indicating that SARS-CoV-2 may transiently impair cognitive function and adversely affect the mood. No improvement in MoCA was observed in 40.5% of the patients at follow-up, indicating possible long-term effects of COVID-19 on global cognitive performance. Medical comorbidities (p = 0.035) significantly predicted the change in MoCA score over time, while fat mass (FM, p = 0.518), Mediterranean diet index (p = .0.944), and Florida Cognitive Activities Score (p = 0.927) did not. These results suggest that the patients’ medical comorbidities at the time of SARS-CoV-2 infection could importantly contribute to the acute impairment of cognitive function and stress the importance of systemic implementation of countermeasures to limit the negative consequences on public health. Frontiers Media S.A. 2023-05-26 /pmc/articles/PMC10252562/ /pubmed/37303911 http://dx.doi.org/10.3389/fpsyg.2023.1141809 Text en Copyright © 2023 Peskar, Šimunič, Šlosar, Pišot, Teraž, Gasparini, Pišot and Marusic. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychology
Peskar, Manca
Šimunič, Boštjan
Šlosar, Luka
Pišot, Saša
Teraž, Kaja
Gasparini, Mladen
Pišot, Rado
Marusic, Uros
Effects of COVID-19 on cognition and mood after hospitalization and at 2-month follow-up
title Effects of COVID-19 on cognition and mood after hospitalization and at 2-month follow-up
title_full Effects of COVID-19 on cognition and mood after hospitalization and at 2-month follow-up
title_fullStr Effects of COVID-19 on cognition and mood after hospitalization and at 2-month follow-up
title_full_unstemmed Effects of COVID-19 on cognition and mood after hospitalization and at 2-month follow-up
title_short Effects of COVID-19 on cognition and mood after hospitalization and at 2-month follow-up
title_sort effects of covid-19 on cognition and mood after hospitalization and at 2-month follow-up
topic Psychology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252562/
https://www.ncbi.nlm.nih.gov/pubmed/37303911
http://dx.doi.org/10.3389/fpsyg.2023.1141809
work_keys_str_mv AT peskarmanca effectsofcovid19oncognitionandmoodafterhospitalizationandat2monthfollowup
AT simunicbostjan effectsofcovid19oncognitionandmoodafterhospitalizationandat2monthfollowup
AT slosarluka effectsofcovid19oncognitionandmoodafterhospitalizationandat2monthfollowup
AT pisotsasa effectsofcovid19oncognitionandmoodafterhospitalizationandat2monthfollowup
AT terazkaja effectsofcovid19oncognitionandmoodafterhospitalizationandat2monthfollowup
AT gasparinimladen effectsofcovid19oncognitionandmoodafterhospitalizationandat2monthfollowup
AT pisotrado effectsofcovid19oncognitionandmoodafterhospitalizationandat2monthfollowup
AT marusicuros effectsofcovid19oncognitionandmoodafterhospitalizationandat2monthfollowup